pifithrin has been researched along with Primary Peritonitis in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sutton, TA | 1 |
| Hato, T | 1 |
| Mai, E | 1 |
| Yoshimoto, M | 1 |
| Kuehl, S | 1 |
| Anderson, M | 1 |
| Mang, H | 1 |
| Plotkin, Z | 1 |
| Chan, RJ | 1 |
| Dagher, PC | 1 |
1 other study available for pifithrin and Primary Peritonitis
| Article | Year |
|---|---|
p53 is renoprotective after ischemic kidney injury by reducing inflammation.
Topics: Acute Kidney Injury; Animals; Apoptosis; Benzothiazoles; Bone Marrow Transplantation; Chimera; Cytok | 2013 |